Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Project Tara
NCT06411223Phase 2Active, not recruiting
- Sponsor
- Yale University
- Start
- Aug 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabotegravir, rilpivirine in human immunodeficiency virus infection (HIV), sponsored by Yale University. Started Aug 2024; status: active, not recruiting.
02
Drugs
cabotegravirrilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT06411223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06411223.